CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,113,000 | +165.6% | 218,143 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $419,000 | -74.6% | 218,143 | -50.0% | 0.00% | 0.0% |
Q3 2018 | $1,650,000 | +171.4% | 436,286 | +123.9% | 0.00% | 0.0% |
Q2 2018 | $608,000 | +54.3% | 194,822 | +18.0% | 0.00% | 0.0% |
Q1 2018 | $394,000 | -20.4% | 165,060 | +30.3% | 0.00% | 0.0% |
Q4 2017 | $495,000 | +55.2% | 126,696 | 0.0% | 0.00% | – |
Q3 2017 | $319,000 | -8.9% | 126,696 | 0.0% | 0.00% | – |
Q2 2017 | $350,000 | +171.3% | 126,696 | +14.6% | 0.00% | – |
Q1 2016 | $129,000 | -52.4% | 110,543 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $271,000 | -18.4% | 110,543 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $332,000 | -27.4% | 110,543 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $457,000 | – | 110,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |